Inovio Pharmaceuticals Inc vs Symbotic Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while Symbotic Inc trades at $42 (market cap $5.41B). The key difference: Symbotic Inc is far larger — about 68.9× Inovio Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| INO | SYM | |
|---|---|---|
Market Cap | $78.55M | $5.41B |
Sector | Health | Technology |
52-Week High | $2.87 | $87.30 |
52-Week Low | $0.66 | $38.57 |
Enterprise Value | $49.56M | $3.67B |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →